Anti-IgE therapy in pediatric allergic asthma
Abstract
The therapeutic application of monoclonal antibodies in children is a developing field, though a number of promising results have already been obtained, such as the approval of anti-IgE therapy in pediatric allergic asthma. The aim of this review is to provide a clinical ovierview of anti-IgE therapy, in particular focusing on omalizumab, the first biologic treatment in the field of respiratory allergy....
Read more : http://www.thechild.it/page.php?id=1
Like
Comment
Share